IL17A and tuberculosis: Activation of RAGEs leads to increased inflammation due to the production of reactive oxygen species and proinflammatory cytokines, such as IL-1β and IL17, resulting in defective phagocytosis [53], coupled with an increase in oxidative stress and changes in the distribution of anti-tuberculosis drugs [51].